Keyphrases
Acute Leukemia
100%
Allogeneic Bone Marrow Transplantation
100%
Remission
80%
Bone Marrow Transplantation
40%
Acute Myeloid Leukemia
40%
Acute Lymphoblastic Leukemia
40%
Leukemia Patients
40%
Regression Analysis
40%
Relapse-free
40%
Relapse-free Survival
40%
Graft-versus-host Disease (GvHD)
20%
Treatment Options
20%
Allogeneic
20%
Conventional Chemotherapy
20%
Transplantation Therapy
20%
Aging Effect
20%
Older Patients
20%
Clinical Performance
20%
Confidence Interval
20%
Age Groups
20%
Pretransplant
20%
High Incidence
20%
Performance Status
20%
Long Hospital Stay
20%
Long-term Survival
20%
First Remission
20%
Marrow Transplantation
20%
Conventional Therapy
20%
Remission Status
20%
Overall Outcome
20%
White Cell Count
20%
Transplant Morbidity
20%
Transplant Complications
20%
Clinical Prognostic Factors
20%
Extramedullary Leukemia
20%
Clinical Outcomes
20%
Survival Performance
20%
Nursing and Health Professions
Acute Leukemia
100%
Allogenic Bone Marrow Transplantation
100%
Remission
80%
Bone Marrow Transplantation
40%
Recurrence Free Survival
40%
Acute Lymphoblastic Leukemia
40%
Acute Myeloid Leukemia
40%
Clinical Outcome
20%
Leukocyte Count
20%
Granulocytic Sarcoma
20%
Confidence Interval
20%
Long Term Survival
20%
Leukemia Remission
20%
Acute Graft Versus Host Disease
20%
Medicine and Dentistry
Acute Leukemia
100%
Allogenic Bone Marrow Transplantation
100%
Acute Lymphoblastic Leukemia
40%
Acute Myeloid Leukemia
40%
Bone Marrow Transplantation
40%
Recurrence Free Survival
40%
Leukocyte
20%
Acute Graft Versus Host Disease
20%
Prognostic Factor
20%
Cell Count
20%
Long Term Survival
20%
Leukemia Remission
20%
Myeloid Sarcoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
100%
Remission
80%
Recurrence Free Survival
40%
Acute Myeloid Leukemia
40%
Acute Lymphoblastic Leukemia
40%
Chemotherapy
20%
Acute Graft Versus Host Disease
20%
Long Term Survival
20%
Leukemia Remission
20%
Granulocytic Sarcoma
20%